Recursion Pharmaceuticals, Inc. RXRX Book value per share
Book value per share at other companies
Other financials
Where this comes from
Calculated from Recursion Pharmaceuticals, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Recursion Pharmaceuticals, Inc.'s book value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Recursion Pharmaceuticals, Inc.'s book value per share?
- Recursion Pharmaceuticals, Inc. (RXRX) reported book value per share of $1.94 in Q1 2026.
- How has Recursion Pharmaceuticals, Inc.'s book value per share changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s book value per share decreased by 16.5% year-over-year, from $2.32 to $1.94.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s book value per share?
- Over 5 years (2020 to 2025), Recursion Pharmaceuticals, Inc.'s book value per share has grown at a -23.2% compound annual growth rate (CAGR), from -$9.47 to $2.53.
- What does book value per share mean?
- Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.